Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening
出版年份 2019 全文链接
标题
Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-24
DOI
10.1038/s41598-018-36944-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Importance of secondary screening with clinical isolates for anti-leishmania drug discovery
- (2018) Aya Hefnawy et al. Scientific Reports
- Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
- (2017) REBECCA L. CHARLTON et al. PARASITOLOGY
- Studies in vitro on infectivity and sensitivity to antileishmanial drugs in New World Leishmania species transfected with the green fluorescent protein [pIR3(-)-eGFP]
- (2017) GENESIS PALACIOS et al. PARASITOLOGY
- An Integrated Microfluidic Processor for DNA-Encoded Combinatorial Library Functional Screening
- (2017) Andrew B. MacConnell et al. ACS Combinatorial Science
- The enemy within: Targeting host–parasite interaction for antileishmanial drug discovery
- (2017) Suzanne Lamotte et al. PLoS Neglected Tropical Diseases
- New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence
- (2017) Guilherme D. Melo et al. PLoS Neglected Tropical Diseases
- Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
- (2017) Alicia Ponte-Sucre et al. PLoS Neglected Tropical Diseases
- Haplotype selection as an adaptive mechanism in the protozoan pathogen Leishmania donovani
- (2017) Pablo Prieto Barja et al. Nature Ecology & Evolution
- Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization
- (2017) Sreenivas Gannavaram et al. Scientific Reports
- A ReplicativeIn VitroAssay for Drug Discovery against Leishmania donovani
- (2016) Diana Tegazzini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity
- (2016) Emilie Durieu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Screening out irrelevant cell-based models of disease
- (2016) Peter Horvath et al. NATURE REVIEWS DRUG DISCOVERY
- A touch of Zen: post-translational regulation of theLeishmaniastress response
- (2015) Gerald F. Späth et al. CELLULAR MICROBIOLOGY
- Leishmaniasis
- (2015) Nathanial K. Copeland et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Simultaneous multi-parametric analysis of Leishmania and of its hosting mammal cells: A high content imaging-based method enabling sound drug discovery process
- (2015) Claire-Lise Forestier et al. MICROBIAL PATHOGENESIS
- Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages
- (2015) Tatiana R. de Moura et al. PARASITOLOGY RESEARCH
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
- (2015) Imanol Peña et al. Scientific Reports
- High variability of genomic instability and gene expression profiling in different HeLa clones
- (2015) Annalisa Frattini et al. Scientific Reports
- Combination Therapy with Tamoxifen and Amphotericin B in Experimental Cutaneous Leishmaniasis
- (2014) C. T. Trinconi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- THP-1 cell line: An in vitro cell model for immune modulation approach
- (2014) Wasaporn Chanput et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Regulation Dynamics ofLeishmaniaDifferentiation: Deconvoluting Signals and Identifying Phosphorylation Trends
- (2014) Polina Tsigankov et al. MOLECULAR & CELLULAR PROTEOMICS
- Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
- (2014) Caspar J. Hodiamont et al. PLoS Neglected Tropical Diseases
- Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay
- (2013) Manu De Rycker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment
- (2013) V. Mosimann et al. INFECTION
- Monocytes, Peripheral Blood Mononuclear Cells, and THP-1 Cells Exhibit Different Cytokine Expression Patterns following Stimulation with Lipopolysaccharide
- (2013) Anita Schildberger et al. MEDIATORS OF INFLAMMATION
- The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line
- (2013) Andrew Adey et al. NATURE
- The Genomic and Transcriptomic Landscape of a HeLa Cell Line
- (2013) Jonathan J. M. Landry et al. G3-Genes Genomes Genetics
- High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery
- (2013) Nathalie Aulner et al. PLoS Neglected Tropical Diseases
- What has proteomics taught us about Leishmania development?
- (2012) POLINA TSIGANKOV et al. PARASITOLOGY
- Impact of Continuous Axenic Cultivation in Leishmania infantum Virulence
- (2012) Diana Moreira et al. PLoS Neglected Tropical Diseases
- Leishmania donovani Develops Resistance to Drug Combinations
- (2012) Raquel García-Hernández et al. PLoS Neglected Tropical Diseases
- A Species-Specific Approach to the Use of Non-Antimony Treatments for Cutaneous Leishmaniasis
- (2011) Roshan Ramanathan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation
- (2011) Pascale Pescher et al. CELLULAR MICROBIOLOGY
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
- (2011) Shyam Sundar et al. LANCET
- Antimony Toxicity
- (2010) Shyam Sundar et al. International Journal of Environmental Research and Public Health
- Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds
- (2010) Jair L. Siqueira-Neto et al. PLoS Neglected Tropical Diseases
- In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
- (2009) M. Vermeersch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Susceptibility of Field Isolates of Leishmania donovani to Miltefosine and Amphotericin B: Correlation with Sodium Antimony Gluconate Susceptibility and Implications for Treatment in Areas of Endemicity
- (2008) D. Kumar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started